Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022332
Company: ELI LILLY CO
Company: ELI LILLY CO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ADCIRCA | TADALAFIL | 20MG | TABLET;ORAL | Prescription | AB2 | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/22/2009 | ORIG-1 | Approval | Type 6 - New Indication (no longer used) | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022332lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022332s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022332_adcirca_toc.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/15/2020 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022332Orig1s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022332Orig1s011ltr.pdf | |
05/05/2017 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022332s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022332Orig1s009ltr.pdf | |
04/02/2015 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022332s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022332Orig1s007ltr.pdf | |
04/29/2014 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022332s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022332Orig1s006ltr.pdf | |
11/20/2013 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022332s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022332Orig1s005ltr.pdf | |
02/08/2011 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022332s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022332s003ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/15/2020 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022332Orig1s011lbl.pdf | |
05/05/2017 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022332s009lbl.pdf | |
04/02/2015 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022332s007lbl.pdf | |
04/29/2014 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022332s006lbl.pdf | |
11/20/2013 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022332s005lbl.pdf | |
02/08/2011 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022332s003lbl.pdf | |
05/22/2009 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022332lbl.pdf |
ADCIRCA
TABLET;ORAL; 20MG
TE Code = AB2
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ADCIRCA | TADALAFIL | 20MG | TABLET;ORAL | Prescription | Yes | AB2 | 022332 | ELI LILLY CO |
ALYQ | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 216932 | TEVA PHARMS INC |
ALYQ | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 209942 | TEVA PHARMS USA |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 210392 | AJANTA PHARMA LTD |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 206286 | AUROBINDO PHARMA LTD |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 210572 | CHARTWELL RX |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 210255 | CIPLA |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 210145 | DR REDDYS |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 209907 | HETERO LABS LTD III |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 207290 | MACLEODS PHARMS LTD |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 210608 | PRINSTON INC |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 213496 | SUNSHINE |
TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL | Prescription | No | AB2 | 212062 | TORRENT |